A detailed history of Cubist Systematic Strategies, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 23,436 shares of ARCT stock, worth $429,816. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,436
Holding current value
$429,816
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.08 - $25.38 $423,722 - $594,805
23,436 New
23,436 $543,000
Q1 2024

May 15, 2024

SELL
$31.23 - $42.99 $377,695 - $519,921
-12,094 Reduced 99.25%
92 $3,000
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $215,814 - $401,772
12,186 New
12,186 $384,000
Q2 2023

Aug 14, 2023

SELL
$23.94 - $32.36 $2.1 Million - $2.83 Million
-87,565 Reduced 70.4%
36,817 $1.06 Million
Q1 2023

May 15, 2023

BUY
$14.72 - $23.97 $1.02 Million - $1.67 Million
69,517 Added 126.71%
124,382 $2.98 Million
Q4 2022

Feb 14, 2023

BUY
$14.14 - $23.06 $775,791 - $1.27 Million
54,865 New
54,865 $930,000
Q2 2022

Aug 15, 2022

BUY
$12.26 - $31.17 $423,141 - $1.08 Million
34,514 Added 659.29%
39,749 $626,000
Q1 2022

May 16, 2022

BUY
$17.64 - $39.57 $92,345 - $207,148
5,235 New
5,235 $141,000
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $536,392 - $745,931
-15,684 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $185,290 - $387,129
6,646 Added 73.53%
15,684 $749,000
Q2 2021

Aug 16, 2021

SELL
$25.79 - $42.11 $516,883 - $843,968
-20,042 Reduced 68.92%
9,038 $306,000
Q1 2021

May 17, 2021

BUY
$38.75 - $86.92 $1.13 Million - $2.53 Million
29,080 New
29,080 $1.2 Million
Q4 2020

Feb 16, 2021

SELL
$34.61 - $123.66 $344,784 - $1.23 Million
-9,962 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$37.49 - $63.19 $811,208 - $1.37 Million
-21,638 Reduced 68.47%
9,962 $427,000
Q2 2020

Aug 14, 2020

BUY
$12.66 - $58.27 $400,056 - $1.84 Million
31,600 New
31,600 $1.48 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $487M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.